title: Drofenine: A 2-APB Analogue with Greater Selectivity for Human TRPV3.
abstract: Transient receptor potential vanilloid-3 (TRPV3) is a member of the TRPV subfamily of TRP ion channels. The physiological functions of TRPV3 are not fully understood, in part due to a lack of selective agonists and antagonists that could both facilitate the elucidation of roles for TRPV3 in mammalian physiology, as well as potentially serve as therapeutic agents to modulate conditions for which altered TRPV3 function has been implicated. In this study, the Microsource Spectrum Collection was screened for TRPV3 agonists and antagonists using alterations in calcium flux in TRPV3 over-expressing HEK-293 cells. The antispasmodic agent drofenine was identified as a new TRPV3 agonist. Drofenine exhibited similar potency to the known TRPV3 agonists 2-aminoethoxydiphenylboronate (2-APB) and carvacrol in HEK-293 cells, but greater selectivity for TRPV3 based on a lack of activation of TRPA1, V1, V2, V4, or M8. Multiple inhibitors were also identified, but all of the compounds were either inactive or not specific. Drofenine activated TRPV3 via interactions with the residue, H426, which is required for TRPV3 activation by 2-APB. Drofenine was a more potent agonist of TRPV3 and more cytotoxic than either carvacrol or 2-APB in human keratinocytes and its effect on TRPV3 in HaCaT cells was further demonstrated using the antagonist icilin. Due to the lack of specificity of existing TRPV3 modulators and the expression of multiple TRP channels in cells/tissue, drofenine may be a valuable probe for elucidating TRPV3 functions in complex biological systems. Identification of TRPV3 as a target for drofenine may also suggest a mechanism by which drofenine acts as a therapeutic agent.
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, 30 S. 2000 E., Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
authors.forename: Cassandra E
authors.initials: CE
authors.lastname: Deering-Rice
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, 30 S. 2000 E., Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
authors.forename: Virginia K
authors.initials: VK
authors.lastname: Mitchell
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, 30 S. 2000 E., Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
authors.forename: Erin G
authors.initials: EG
authors.lastname: Romero
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, 30 S. 2000 E., Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
authors.forename: May H
authors.initials: MH
authors.lastname: Abdel Aziz
authors.affiliation: Department of Ophthalmology & Visual Sciences, Interdepartmental Neuroscience Program, University of Utah, Room S4140 Moran Eye Center, Salt Lake City, UT 84132, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Ryskamp
authors.affiliation: Department of Ophthalmology & Visual Sciences, Interdepartmental Neuroscience Program, University of Utah, Room S4140 Moran Eye Center, Salt Lake City, UT 84132, USA.
authors.forename: David
authors.initials: D
authors.lastname: Križaj
authors.affiliation: Department of Medicinal Chemistry, University of Utah, Salt Lake City, UT 84112.
authors.forename: V Raj
authors.initials: VR
authors.lastname: Gopal
authors.affiliation: Department of Pharmacology and Toxicology, University of Utah, 30 S. 2000 E., Room 201 Skaggs Hall, Salt Lake City, UT 84112, USA.
authors.forename: Christopher A
authors.initials: CA
authors.lastname: Reilly
keywords: 2-APB; Drofenine; Drug screening; TRP channels; TRPV3; TRPV3 agonist; TRPV3 antagonist; carvacrol; cutaneous physiology; drug discovery; receptor mechanisms
references.citation: Exp Mol Med. 2013 Mar 08;45:e12
references.pmid: 23470714
references.citation: J Physiol. 2014 Jan 15;592(2):295-304
references.pmid: 23836684
references.citation: Proc Natl Acad Sci U S A. 2009 Feb 3;106(5):1626-31
references.pmid: 19164517
references.citation: FASEB J. 2002 Aug;16(10):1145-50
references.pmid: 12153982
references.citation: Am J Hum Genet. 2012 Mar 9;90(3):558-64
references.pmid: 22405088
references.citation: FASEB J. 2013 Sep;27(9):3549-63
references.pmid: 23722916
references.citation: Mol Pharmacol. 2012 Mar;81(3):411-9
references.pmid: 22155782
references.citation: Chem Res Toxicol. 2013 May 20;26(5):750-8
references.pmid: 23541125
references.citation: FASEB J. 2008 Aug;22(8):3024-34
references.pmid: 18492727
references.citation: J Neurosci. 2011 May 11;31(19):7089-101
references.pmid: 21562271
references.citation: Nat Neurosci. 2006 May;9(5):628-35
references.pmid: 16617338
references.citation: J Assoc Res Otolaryngol. 2011 Dec;12(6):729-40
references.pmid: 21879401
references.citation: J Biol Chem. 2010 Jun 18;285(25):19362-71
references.pmid: 20395302
references.citation: Br J Pharmacol. 2014 May;171(10):2474-507
references.pmid: 24102319
references.citation: J Neurosci. 2004 Jun 2;24(22):5177-82
references.pmid: 15175387
references.citation: Exp Eye Res. 2010 Jan;90(1):121-9
references.pmid: 19793539
references.citation: Br J Pharmacol. 2007 Jun;151(4):530-40
references.pmid: 17420775
references.citation: J Biol Chem. 2004 May 14;279(20):21569-75
references.pmid: 15004014
references.citation: J Neurosci. 2008 Dec 3;28(49):13056-65
references.pmid: 19052196
references.citation: Mol Pharmacol. 2010 Apr;77(4):612-20
references.pmid: 20086034
references.citation: Chem Res Toxicol. 2011 Jun 20;24(6):950-9
references.pmid: 21591660
references.citation: J Biol Chem. 2012 Mar 2;287(10):7279-88
references.pmid: 22184123
references.citation: Biochemistry. 2011 Jul 26;50(29):6295-300
references.pmid: 21696149
references.citation: ScientificWorldJournal. 2012;2012:982725
references.pmid: 22548000
references.citation: Zebrafish. 2010 Mar;7(1):3-11
references.pmid: 20192852
references.citation: Science. 2002 Jun 14;296(5575):2046-9
references.pmid: 12016205
references.citation: Cell. 2007 Apr 6;129(1):220
references.pmid: 17418797
references.citation: J Biol Chem. 2003 Aug 22;278(34):32037-46
references.pmid: 12783886
references.citation: J Biol Chem. 2012 Jul 27;287(31):25905-16
references.pmid: 22679014
references.citation: Exp Lung Res. 2008 Dec;34(10):681-93
references.pmid: 19085565
references.citation: J Biol Chem. 2005 Apr 22;280(16):15928-41
references.pmid: 15722340
references.citation: Br J Pharmacol. 2012 Feb;165(3):683-92
references.pmid: 21718307
references.citation: Pain. 2011 May;152(5):1156-1164
references.pmid: 21353389
references.citation: Exp Dermatol. 2013 Jul;22(7):447-52
references.pmid: 23800054